Introduction. While evidence suggests that beginning an external cephalic version (ECV) before term (34 0/7 to 36 6/7 weeks) compared with after term may be associated with an increase in late preterm birth (34 0/7 to 36 6/7 weeks), it remains unknown what might account for this risk. The objective of the present study is to further investigate the association between ECV before term and late preterm birth. Material and methods. Secondary analysis of data collected from the international, multicenter Early ECV trials. We evaluated the relation between ECV exposure and late preterm birth (34 0/7 to 36
Introduction
External cephalic version (ECV) is an obstetric maneuver used to manually turn a fetus from breech to cephalic presentation by externally manipulating the fetus through the maternal abdomen (1) . Generally, an ECV is attempted when a women has reached term (i.e. 37 weeks' gestation). However, a recent Cochrane review found that relative to women randomized to
Key Message
Among women with low-risk pregnancies, performing an external cephalic version before term in those with an anterior placenta doubles the odds of late preterm birth.
receive an ECV completed at term (i.e. 37 0/7 weeks onwards; "late ECV"), women randomized to receive an ECV before term (i.e. <37 0/7 weeks' gestation; "early ECV") had a decreased likelihood of the following: non-cephalic presentation at birth, failing to achieve a cephalic vaginal birth, and having a vaginal breech birth (2) . However, the odds of late preterm birth (34 0/ 7 to 36 6/7 weeks) was increased for the women randomized to the early ECV group compared with the late ECV group [odds ratio (OR) 1.51; 95% CI 1.03-2.21] (2).
Given the poorer prognosis of infants born late preterm (3, 4) , it is of particular importance to examine how ECV before term contributes to odds of late preterm birth. Here, we wished to extend the literature on the association between early ECV and late preterm birth in at least five ways. First, we performed the perprotocol analysis to examine how actual exposure to an ECV before term contributes to odds of late preterm birth. Secondly, we investigated this relation while controlling for the influence of other risk factors for preterm birth. Thirdly, we examined whether any factors moderated the association between early ECV and late preterm birth. Fourthly, we explored possible mechanisms underlying the association between early ECV and late preterm birth. Finally, we described the subset of women who received an ECV before term and who also delivered preterm. Collectively, the present study aims to provide a more detailed and exhaustive approach to investigating the association of early ECV and late preterm birth. These findings will be useful in guiding the counseling and obstetric management of individual women with low-risk breech pregnancies.
Material and methods
The objective was addressed using three research questions. The first two questions were predictive in nature and included the following: (i) Among all women enrolled in the study, is exposure to an ECV before term associated with late preterm birth after controlling for known risk factors for preterm birth? (ii) Among all women who received at least one ECV before term, what factors are associated with late preterm birth? The third question was descriptive in nature: What are the characteristics of women who received an ECV before 37 weeks and delivered preterm?
Data used to answer these research questions were collected as part of the Early ECV Pilot trial (n = 233) (1), and the Early ECV2 trial (n = 1543) (5) . Collectively, these two trials will be referred to as the Early ECV (EECV) trials. The EECV trials recruited women from a total of 22 countries, with a total of 81 participating centers. Full methodology of these randomized controlled trials (RCTs) has been described elsewhere (1, 5) .
Women were eligible for enrollment if they had a singleton fetus in breech presentation and were between 33 0/7 weeks and 35 6/7 weeks' gestation. Women were ineligible if they were at risk for unstable lie, if they planned to move to a non-trial center, if they had a contraindication to labor or vaginal birth, a contraindication to ECV, a contraindication to early ECV (including an increased risk for preterm birth or previous preterm birth), if they planned to give birth by cesarean section even if the fetus turned into a cephalic position and/or if they planned a vaginal birth even if the breech remained breech (1, 5 Since the early ECV was not administered before 34 0/7 weeks (1,5), the primary outcome was restricted to looking at late preterm birth (late preterm = 34 0/7 to 36 6/7 weeks' gestation at delivery vs. term ≥37 0/7 weeks' gestation at delivery). For the first research question, the primary predictor of interest was exposure to at least one ECV before term (vs. no ECV before 37 weeks). Data available on known risk factors for preterm birth were statistically controlled for and included maternal age at delivery (<35 years vs. ≥35 years), maternal body mass index (BMI) at time of enrollment (BMI <25 kg/m 2 , BMI 25-29.9 kg/m 2 , and BMI ≥30 kg/m 2 ), maternal height (shorter stature (<167 cm) vs. taller stature (≥167 cm) (6), parity (nulliparous vs. multiparous), placenta location (non-anterior vs. anterior), and perinatal mortality rate (PMR) of the woman's country (PMR ≤10/1000 vs. PMR >10/1000) (7).
For the second research question, our primary outcome was late preterm birth. In addition to including the above risk factors as predictors for preterm birth, ECV procedural-related variables were also considered. These included the station of the presenting part prior to the ECV procedure (floating/dipping vs. well engaged into pelvis), use of tocolytics (no vs. yes), and pain during ECV (selfreported by women using a visual analogue scale ranging from 0 to 100, with the lower endpoint signifying no pain and the higher endpoint signifying the most pain imaginable). We chose these variables in particular because we were interested in factors prior or during the ECV itself that could be of utility to clinicians in predicting preterm birth among women receiving an ECV.
Analysis
Sample characteristics for women who received an ECV before term and women who did not receive an ECV before term were examined using independent sample t-tests for continuous variables, with means and standard deviations reported. For dichotomous variables, chisquare tests explored group differences, and counts and percentages were reported.
For the first question of our predictive approach, participants included all women enrolled in the EECV trials. There were three statistical models examined to investigate the influence of early ECV on late preterm birth. First, univariable binary logistic regression was used to provide the unadjusted estimates for the influence of each predictor variable on the odds of late preterm birth. Secondly, we performed multivariable binary logistic regression to obtain an adjusted model. This provides information on the influence of an independent variable on the outcome while accounting for the effect of other variables. In the first block of the multivariable model we included risk factors for preterm birth including maternal age, parity, maternal height, maternal BMI, placenta location, and PMR. In the second block of the model we included the exposure of interest, which was an ECV before term. Finally, in the third block we explored the inclusion of interactions between the aforementioned risk factors and ECV exposure. Rationale for this approach was to identify potential subgroups of women who might be at risk for preterm birth when they are exposed to an ECV before term.
It has been speculated that in RCTs with multiple centers, patient outcomes differ according to study center. Because of this, many RCTs attempt to minimize the impact of any between-center differences on the trial results by randomizing patients within center and additionally accounting for the influence of differences between centers in the analysis model (8) . A statistical method to control for the effect of center is the generalized linear mixed model (GLMM), and we therefore used this in our third model (8, 9) . Specifically, trial center was entered as a random effect, which allows the participants within centers to have variation in outcomes as opposed to treating the entire population as identical. Low-recruiting centers in RCTs contribute small number of participants (10), therefore sensitivity analyses were also performed excluding centers that recruited fewer than five patients.
To address our second research question, we again considered three statistical approaches as above (i.e. univariable logistic, multivariable logistic, GLMM). Participants included women enrolled in the EECV trials who received at least one ECV before term and where the outcome was late preterm birth. In the first block of our models, risk factors for preterm birth including maternal age, parity, maternal height, maternal BMI, placenta location, and PMR were included. In the second block of our models, the procedural-specific variables of interest were entered (i.e. station of presenting part, tocolytic use, and pain).
For our third research question, we described the subset of women who had the exposure of interest (i.e. ECV before term) and the outcome of interest (i.e. late preterm birth). First, all women who delivered preterm (n = 101) were compared based on their exposure to ECV before term. This resulted in a comparison of 48 women who had an ECV before term and delivered preterm, and 53 women who did not have an ECV before term but delivered preterm ( Figure 1 ). Group differences on risk factors for preterm birth were examined using chi-square analysis.
Secondly, the subset of women who had the exposure and outcome of interest (n = 48) was explored further. Time in hours from the early ECV exposure to the preterm delivery was examined. Preterm births that occurred within 96 h of the ECV exposure were classified as potentially being associated with the ECV procedure. Information on available complications (defined as placental abruption, non-reassuring fetal heart rate, signs/symptoms of preterm labor) was examined in the women who delivered within 96 h of ECV exposure. The rationale for this was to explore whether we could identify any specific mechanism by which an ECV might be associated with a preterm birth.
Finally, to further examine the role of early ECV on late preterm birth, characteristics among the subset of women who delivered within 48 h of the early ECV exposure were explored. It was felt that a time period of 48 h would more precisely represent the preterm delivery being attributable to the early ECV procedure, although it is acknowledged that the study design does not allow for certainty of this association. The statistical software package SPSS 21.0 (SPSS Inc., Chicago, IL, USA) was used for all data analyses.
Results

Sample characteristics
In total, 1776 women were enrolled in the EECV trials. Nine participants were lost to follow up and two withdrew from the trials. This resulted in a dataset with 1765 women included in the analyses with the preterm birth outcome variable. A total of 749 women received at least one ECV before term. A total of 1016 women did not receive an ECV before term. These two groups did not differ significantly on any characteristics (Table 1) .
Predictors of preterm birth among all women enrolled: exposure to ECV before term
The completely adjusted GLMM model revealed that, independent of early ECV exposure, living in a country with a PMR >10/1000 was a significant predictor of preterm birth (OR 2.37; 95% CI 1.49-3.77; p < 0.001; Table 2 ). Although early ECV exposure was not an independent predictor of preterm birth overall, the interaction between early ECV and placenta location was a significant predictor after adjusting for all other variables and controlling for center-effect (p < 0.05; Table 2 ). There were no significant interactions between early ECV exposure and other risk factors. Sensitivity analyses revealed that exclusion of low recruiting centers did not affect the significance of the results.
Decomposition of the interaction between ECV exposure and placental location revealed that ECV exposure before term increased the odds of preterm birth in women with anterior placenta location (OR 2.05; 95% CI 1.12-3.71; p = 0.02) but not in women without anterior placenta location (OR 0.69; 95% CI 0.38-1.26; p = 0.23; Figure 2 ).
Predictors of preterm birth among women who received an ECV before term
The completely adjusted GLMM model revealed that anterior placenta location was a significant predictor of preterm birth (OR 1.94; 95% CI 1.09-3.46; p = 0.03; Table 3 ). The odds of preterm birth were also increased for women with a baby well engaged into the pelvis prior to the ECV procedure relative to women with a floating/dipping fetus (OR 2.11; 95% CI 1.12-3.96; p = 0.02; Table 3 ). Sensitivity analyses revealed that exclusion of low-recruiting centers did not affect the significance of the results.
Description of women who received an ECV before term and delivered preterm
In total, 48 women received an ECV before term and delivered preterm (Figure 1) . After comparing all women who delivered preterm (n = 101), stratified by exposure status (early ECV vs. no early ECV), there was a significant difference in placenta location for these two groups [v 2 (1, n = 100) = 4.01, p = 0.04)] (data on placenta location was missing for one participant). Women who received an ECV before term and delivered preterm were significantly more likely to have an anterior placenta (61.7%) compared with the women who did not receive an ECV before term and had a preterm birth (39.6%).
There was no significant difference on maternal age, BMI, parity, height, or PMR among the exposure groups. Figure 3 displays the distribution of time in hours from ECV exposure before term to time of preterm delivery. Of the subset of women who received an ECV before term and delivered preterm (n = 48), 20 women delivered within 96 h of the ECV exposure, with the remaining 28 delivering after 96 h of ECV exposure. Among the women who delivered within 96 h of the early ECV exposure (n = 20), there was a total of four cases non-reassuring fetal heart rate, no cases of known placenta abruption, and nine women who had signs of preterm labor.
Further exploration was made on the subset of women who delivered within 48 h of the ECV procedure (n = 13). When placenta location was explored among this subset of women, 75% of the women had an anterior placenta, which is approximately double the proportion of anterior placenta relative to the sample of women in the trials. There was no evidence of disproportions for the other preterm risk factors in this group, including maternal height, age, BMI, parity or PMR.
Discussion
A recent Cochrane review (2) reported a 51% increase in the likelihood of preterm birth among women randomized to have an early ECV, and the present study sought to further investigate the association between exposure to an early ECV and odds of late preterm birth among Results of generalized linear mixed model accounting for center-effect. *p < 0.10. **p < 0.05. women at low risk of preterm birth, including no previous preterm birth. We report that early ECV exposure is not independently associated with late preterm birth; however, consistent across study approaches, we provide robust evidence that there is a link between early ECV, anterior placenta location, and preterm birth. The association between early ECV and preterm birth was moderated by anterior placental location with the odds of preterm birth being doubled when these conditions were met. The mechanism by which this risk manifests is not clear from this study; however, two possible pathways are postulated.
Early ECV Exposure status
One biological pathway linked to preterm birth that is plausible in the present study is placental hemorrhage (11) . During the 1980s, authors conducting ECV trials at term deemed anterior placental location as a contraindication for ECV because of a possibility for higher risk of placental abruption and fetal-maternal hemorrhage (12) . However, there has not been a clear causal relationship elucidated between placenta location and the occurrence of these complications at term (13) . Therefore, most studies in modern day do not classify anterior placenta location as a contraindication to ECV, nor do clinical practice guidelines.
In line with previous authors' hypotheses (12) , it is possible that performing an ECV in women with an anterior placenta might disrupt the maternal-fetal interface to result in damaged arteries and placenta hemorrhage (14) . Although there were no reported cases of placental abruption among the women who received an ECV before term and delivered preterm, it is possible that covert internal bleeding occurred following the early ECV procedure that did not manifest clinically as vaginal bleeding and was not captured on case report forms. A high proportion of women who received an ECV before term and delivered preterm (62%) had an anterior placenta. An even higher proportion (75%) of the women who received an ECV before term and delivered within 48 h of the procedure had an anterior placenta. This proportion of anterior placenta is approximately double of what was observed among all women enrolled in the trial, and more than double the rate reported among breech pregnancies in other studies (15) . Previous research has shown more histological evidence of bleeding in placentas that were from preterm births than among placentas of term born infants, providing additional evidence that asymptomatic placental disruption resulting from ECV with an anterior placenta might lie in the causal pathway of preterm birth (16) .
A second plausible pathway is fetal intolerance of the ECV. An anteriorly located placenta stands literally between the fetus and the care provider, and hence must be manipulated during an ECV. In these circumstances, a clinician may use increased pressure and force while performing the ECV (17) . Particularly for an immature (i.e. preterm) fetus, the more forceful external manipulation accompanying the ECV in women with an anterior placenta may induce a fetal distress response and stimulate the synthesis of stress hormones (for example corticotropin-releasing hormone, fetal pituitary adrenocorticotropic hormone, cortisol) (18) . Increases of these stress hormones are a major risk factor for preterm labor and premature rupture of the membranes (19, 20) .
It is important to interpret the findings of the present study acknowledging the following limitations. Given the nature of the study (i.e. secondary data analysis), variables were limited to the data collected in the original EECV trials. As a result, there were a number of known risk factors for preterm birth (for example alcohol/substance use, psychiatric history, nutritional status) that were not considered during data collection. Therefore, the results presented are a limited model of clinical predictors of preterm delivery among women with breech presentation and there may be additional subgroups aside from those with an anterior placenta that are at heightened odds for preterm birth when undergoing an ECV before term.
It should also be noted that enrollment criteria excluded participants that were at risk for preterm delivery (including previous preterm birth) and this may reflect the overall low rate of late preterm birth (5-6%) that was observed relative to other population estimates (7-8%) (21) , and also restricts the generalizability of these results to women with low-risk breech pregnancies. Finally, given the outcome explored in the present study was relatively rare, some analyses were underpowered which may have affected our ability to detect statistically significant findings. Despite these limitations, the present study has several strengths. The consistency of findings across analytic approaches enhances plausibility and the large sample of women from international centers increases the generalizability of findings. This is a novel examination of moderating variables on the relation between ECV before term and late preterm birth.
Among women receiving an ECV before term, the odds of delivering preterm among women with an anterior placenta were twice those of women without an anterior placenta. It is speculated that this risk may manifest through biological pathways involved in preterm birth. Additional research is needed to fully elucidate the mechanisms by which an anterior placenta might interact with an ECV before term and result in a preterm birth. This work has important clinical implications that contribute knowledge on risk factors associated with late preterm birth. Although our work is exploratory, it would seem prudent for medical professionals to assess carefully the risk of preterm birth for women undergoing an ECV before term, recognizing that those with an anterior placenta may be at a particularly high risk.
